R. Casaburi (Torrance, Ca, United States Of America), S. L. Johnston (London, United Kingdom)
Clara cell secretory protein and its mRNA expression in induced sputum of acute bacterial exacerbations of COPD
L. Feng Ming, W. ZengLi (Chengdu, China)
|  |
Induced sputum cytology at different etiology of exacerbation of chronic obstructive bronchitis
E. B. Bukreeva, S. V. Nesterovich, E. A. Dementyeva, T. G. Melnik, L. V. Gudkova, E. A. Gereng, I. I. Ivanchuk (Tomsk, Russia)
| |
IgG immunoglobulin levels and the frequency of respiratory infections in patients with chronic obstructive pulmonary disease (COPD)
E. Tsaroucha, G. Pavlakou, D. Antoniou, E. Tsigou, N. Tzogas, H. Ablianitis, E. Anastasakou, O. Anagnostopoulou (Athens, Greece)
| |
COPD exacerbation etiological and therapeutically aspects
I. G. S. Stoica (Bucharest, Romania)
| |
Risk factors associated with observed severity and frequency of 137 first exacerbations (AECB) in 618 consecutive chronic bronchitis (CB) outpatients
S. Damato, T. Camnasio, V. Frigo, C. Rampoldi, F. Rodi, S. Vernocchi (Seregno, Italy)
| |
Pneumococcal bronchial Infection vs colonization in COPD: differences in urine antigens
J. Ruiz, F. Andreo, J. Dominguez, J. Casas, A. Rossell, S. Blanco, N. Galí, J. M. Manterola, V. Ausina, J. Morera (Badalona, Spain)
| |
Bacterial infections in patients with acute exacerbation of chronic obstructive pulmonary diseases
L. Nagorni-ObradoviĆ, D. JovanoviĆ, A. Blanka, S. PopeviĆ (Belgrade, Yugoslavia)
| |
A clinical and outcomes assessment of the management of acute episodes of chronic bronchitis (AECB) : the MOSAIC study - baseline characteristics of screened patients
R. Wilson, P. Jones, T. Schaberg, P. Davey, L. Allegra, J. L. Izquierdo, P. Arvis, I. Duprat Lomon, M. A. Le Berre, G. Huchon (London, Dundee, United Kingdom; Rotenburg, Germany; Milan, Italy; Guadalajara, Spain; Puteaux, Paris, France)
| |
Haemophilus influenzae in COPD patients with poorer lung function carry more antibiotic resistance
A. Leanord, D. Raeside, J. Gravil, C. Williams (Airdrie, Paisley, Hull, United Kingdom)
| |
Efficacy of azithromycin vs. ciprofloxacin in the treatment of patients with acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD)
M. D. Filipovic, S. S. Cekic, O. B. Dimitrijevic (Nis, Yugoslavia)
| |
COPD is associated with high levels of bacterial antibiotic resistance
F. Blasi, R. Cosentini, P. Tarsia, V. Popescu-Janu, C. Gambardella, G. Graziadei, C. Canetta, L. Allegra (Milan, Italy)
| |
Most frequent infecting agents caused acute exacerbation of COPD and their suspectability to the different types of penicillins
K. E. Bogatska, K. Y. Gashynova (Dniepropetrovsk, Ukraine)
| |
Comparative efficacy and safety of five-day moxifloxacin and seven-day ceftriaxone treatment of AECB: results of the SMART study
C. Grassi, G. Schito, L. Casali, E. Curti, M. Tellarini (Pavia, Genova, Perugia, Milano, Italy)
| |
3-day azithromycin (AZM) 500 mg qd versus 10-day clarithromycin (CLA) 500 mg bid for acute exacerbation of chronic bronchitis (AECB) in adults
R. N. Swanson, A. Lainez-Ventosilla, M. C. De Salvo, S. Chodosh, M. W. Dunne (New York, Wayland, United States Of America; La Uruca, Costa-Rica; Buenos Aires, Argentina)
| |
Telithromycin is effective in the treatment of patients with acute exacerbations of chronic bronchitis and risk factors for morbidity
M. Zervos, S. Jenkins, R. Nusrat (Royal Oak, Bridgewater, United States Of America)
| |
Pharmacodynamics of levofloxicin in patients with acute exacerbation of chronic bronchitis
M. Cazzola, M. G. Matera, G. Donnarumma, A. Salzillo, F. Marchetti, M. A. Tufano, F. Blasi (Naples, Verona, Milan, Italy)
| |
Immunomodulators in preventing recurrent respiratory tract infections (RRTI): a meta-analysis*
M. L. Y. Villaroman, L. J. Codamos, M. A. S. Gappi, M. A. de Castro (Quezon City, The Philippines)
| |
Application of low intensity laser radiation in community acquired pneumonias treatment
A. A. Visel, F. A. Mingaleev, O. G. Kataev, N. B. Amirov (Kazan, Russia)
| |